Comments

BioLine Rx

BLRXNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.820000
0.00750.92%
Last update: 9:19 AM
15 minutes delayed
BioLine Rx (BLRX) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$21.00
Lowest Price Target1
$4.00
Consensus Price Target1
$12.50

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

BioLine Rx (NASDAQ:BLRX) Stock, Analyst Ratings, Price Targets, Forecasts

BioLine Rx Ltd has a consensus price target of $12.5 based on the ratings of 2 analysts. The high is $21 issued by HC Wainwright & Co. on June 3, 2024. The low is $4 issued by Oppenheimer on May 25, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 3, 2024, May 29, 2024, and April 17, 2024, respectively. With an average price target of $21 between HC Wainwright & Co., there's an implied 2460.98% upside for BioLine Rx Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Feb
0
0
0
0
Mar
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Oppenheimer

1calculated from analyst ratings

Analyst Ratings for BioLine Rx

Buy NowGet Alert
06/03/2024Buy Now2460.98%HC Wainwright & Co.
Joseph Pantginis
$21 → $21ReiteratesBuy → BuyGet Alert
05/29/2024Buy Now2460.98%HC Wainwright & Co.
Joseph Pantginis
 → $21ReiteratesBuy → BuyGet Alert
04/17/2024Buy Now2460.98%HC Wainwright & Co.
Joseph Pantginis
—ReiteratesBuy → BuyGet Alert
03/26/2024Buy Now2460.98%HC Wainwright & Co.
Joseph Pantginis
 → $21ReiteratesBuy → BuyGet Alert
02/29/2024Buy Now2460.98%HC Wainwright & Co.
Joseph Pantginis
 → $21ReiteratesBuy → BuyGet Alert
11/20/2023Buy Now2460.98%HC Wainwright & Co.
Joseph Pantginis
 → $21ReiteratesBuy → BuyGet Alert
09/15/2023Buy Now2460.98%HC Wainwright & Co.
Joseph Pantginis
$19 → $21MaintainsBuyGet Alert
08/31/2023Buy Now2217.07%HC Wainwright & Co.
Joseph Pantginis
 → $19ReiteratesBuy → BuyGet Alert
05/25/2023Buy Now387.8%Oppenheimer
Mark Breidenbach
 → $4Reiterates → OutperformGet Alert

FAQ

Q

What is the target price for BioLine Rx (BLRX) stock?

A

The latest price target for BioLine Rx (NASDAQ:BLRX) was reported by HC Wainwright & Co. on June 3, 2024. The analyst firm set a price target for $21.00 expecting BLRX to rise to within 12 months (a possible 2460.98% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for BioLine Rx (BLRX)?

A

The latest analyst rating for BioLine Rx (NASDAQ:BLRX) was provided by HC Wainwright & Co., and BioLine Rx reiterated their buy rating.

Q

When was the last upgrade for BioLine Rx (BLRX)?

A

There is no last upgrade for BioLine Rx

Q

When was the last downgrade for BioLine Rx (BLRX)?

A

There is no last downgrade for BioLine Rx.

Q

When is the next analyst rating going to be posted or updated for BioLine Rx (BLRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioLine Rx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioLine Rx was filed on June 3, 2024 so you should expect the next rating to be made available sometime around June 3, 2025.

Q

Is the Analyst Rating BioLine Rx (BLRX) correct?

A

While ratings are subjective and will change, the latest BioLine Rx (BLRX) rating was a reiterated with a price target of $21.00 to $21.00. The current price BioLine Rx (BLRX) is trading at is $0.82, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch